|
Operating Revenue
|
|
$529.3m
|
$87.1m
|
$81.9m
|
$75.3m
|
$60.0m
|
|
Revenues
|
|
$529.3m
|
$586.1m
|
$580.0m
|
$541.5m
|
$422.0m
|
|
COST OF REVENUES
|
|
($315.6m)
|
($458.6m)
|
($406.0m)
|
($387.7m)
|
($313.2m)
|
|
GROSS PROFIT
|
|
$213.7m
|
$127.5m
|
$174.0m
|
$153.8m
|
$108.8m
|
|
Total operating expenses
|
|
($161.7m)
|
($180.3m)
|
($419.2m)
|
($133.6m)
|
($86.4m)
|
|
(LOSS)/INCOME FROM OPERATIONS
|
|
$51.9m
|
($52.9m)
|
($245.2m)
|
$20.1m
|
$22.4m
|
|
EBIT
|
|
|
($7.4m)
|
($37.9m)
|
$8.3m
|
$19.7m
|
|
Operating Income
|
|
—
|
($669k)
|
($18.7m)
|
$2.8m
|
$3.2m
|
|
Total Operating Income As Reported
|
|
—
|
($7.9m)
|
($34.6m)
|
$2.8m
|
$3.2m
|
|
Impairment loss for goodwill
|
|
($18.5m)
|
($35.5m)
|
($106.3m)
|
—
|
—
|
|
Impairment loss for long-lived assets
|
|
—
|
($13.7m)
|
($6.6m)
|
—
|
—
|
|
Net Interest Income
|
|
$1.9m
|
$1.8m
|
$3.9m
|
$26.8m
|
$1.7m
|
|
Other Income
|
|
$2.0m
|
$2.2m
|
$1.1m
|
($48k)
|
($470k)
|
|
Loss from bad debt
|
|
—
|
—
|
—
|
—
|
($17.2m)
|
|
Current
|
|
($2.4m)
|
($102k)
|
($166k)
|
($5.6m)
|
($7.3m)
|
|
Deferred
|
|
$1.8m
|
$3.9m
|
$2.7m
|
($548k)
|
$3k
|
|
NET (LOSS)/INCOME
|
|
$54.7m
|
($46.5m)
|
($266.2m)
|
$52.4m
|
$127.6m
|
|
NET (LOSS)/INCOME ATTRIBUTABLE TO MICRO ALGO INC.
|
|
$55.3m
|
($46.8m)
|
($268.2m)
|
$38.6m
|
$113.9m
|
|
Foreign currency translation adjustment
|
|
($455k)
|
($30.6m)
|
($57.5m)
|
$5.0m
|
($50.2m)
|
|
COMPREHENSIVE (LOSS)/INCOME
|
|
$54.3m
|
($77.2m)
|
($323.7m)
|
$57.4m
|
$77.4m
|
|
COMPREHENSIVE (LOSS)/INCOME ATTRIBUTABLE TO MICRO ALGO INC.
|
|
$54.8m
|
($77.2m)
|
($325.8m)
|
$43.6m
|
$63.8m
|
|
Total benefit of/(provision for) income tax
|
|
($547k)
|
$3.8m
|
$2.5m
|
($6.1m)
|
($7.3m)
|
|
(LOSS)/INCOME BEFORE INCOME TAXES
|
|
$55.3m
|
($50.3m)
|
($268.7m)
|
$58.5m
|
$134.9m
|
|
Net Income Common Stockholders
|
|
($538k)
|
($7.0m)
|
($37.9m)
|
$5.4m
|
$16.2m
|
|
Net Income
|
|
($538k)
|
($7.0m)
|
($37.9m)
|
$5.4m
|
$16.2m
|
|
Net Income Attributable to Noncontrolling Interest
|
|
($538k)
|
$35k
|
$2.0m
|
$13.8m
|
$13.7m
|
|
Basic
|
|
$13.96
|
($11.75)
|
($58.79)
|
$10.52
|
$14.87
|
|
Diluted
|
|
$13.96
|
($11.75)
|
($58.79)
|
$3.99
|
$14.87
|
|
Weighted Average Shares Outstanding
|
|
4.0m
|
4.0m
|
4.6m
|
3.7m
|
7.7m
|
|
Weighted Average Shares Outstanding, Diluted
|
|
4.0m
|
4.0m
|
4.6m
|
9.7m
|
7.7m
|
|
Selling expenses
|
|
($5.4m)
|
($3.8m)
|
($2.8m)
|
($2.2m)
|
($2.2m)
|
|
General and administrative expenses
|
|
($34.0m)
|
($34.5m)
|
($24.9m)
|
($19.7m)
|
($21.0m)
|
|
Research and development expenses
|
|
($107.0m)
|
($93.7m)
|
($161.2m)
|
($111.7m)
|
($63.3m)
|
|
Stock compensation expenses
|
|
—
|
—
|
($117.4m)
|
—
|
—
|
|
Non-Operating Income (Expense)
|
|
$1.3m
|
($1.1m)
|
($27.9m)
|
$12.4m
|
$132.3m
|
|
Finance expenses, net
|
|
($1.8m)
|
($444k)
|
($613k)
|
($785k)
|
($3.8m)
|
|
Total other (expense)/income, net
|
|
$3.4m
|
$2.5m
|
($23.5m)
|
$38.4m
|
$112.5m
|